BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25155595)

  • 1. The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.
    Mesa-Arango AC; Trevijano-Contador N; Román E; Sánchez-Fresneda R; Casas C; Herrero E; Argüelles JC; Pla J; Cuenca-Estrella M; Zaragoza O
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6627-38. PubMed ID: 25155595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking the Amphotericin B Resistance Mechanisms in
    Silva LN; Oliveira SSC; Magalhães LB; Andrade Neto VV; Torres-Santos EC; Carvalho MDC; Pereira MD; Branquinha MH; Santos ALS
    ACS Infect Dis; 2020 May; 6(5):1273-1282. PubMed ID: 32239912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
    Spadari CC; Vila T; Rozental S; Ishida K
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
    [No Abstract]   [Full Text] [Related]  

  • 4. ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans.
    Guirao-Abad JP; Sánchez-Fresneda R; Alburquerque B; Hernández JA; Argüelles JC
    Int J Med Microbiol; 2017 Jun; 307(4-5):241-248. PubMed ID: 28412040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of amphotericin B killing kinetics against seven Candida species.
    Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine enhances the effect of amphotericin B against Candida albicans in vitro.
    Zhao L; Jiang J; Zhu Z; Liao Z; Yao X; Yang Y; Cao Y; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):182-93. PubMed ID: 26711896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.
    Vazquez JA; Arganoza MT; Boikov D; Yoon S; Sobel JD; Akins RA
    J Clin Microbiol; 1998 Sep; 36(9):2690-5. PubMed ID: 9705415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rimonabant potentiates the antifungal activity of amphotericin B by increasing cellular oxidative stress and cell membrane permeability.
    Zhang M; Lu J; Duan X; Chen J; Jin X; Lin Z; Pang Y; Wang X; Lou H; Chang W
    FEMS Yeast Res; 2021 Apr; 21(3):. PubMed ID: 33705544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
    Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells.
    Haynes MP; Chong PL; Buckley HR; Pieringer RA
    Biochemistry; 1996 Jun; 35(24):7983-92. PubMed ID: 8672502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells.
    Thangamani S; Eldesouky HE; Mohammad H; Pascuzzi PE; Avramova L; Hazbun TR; Seleem MN
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3002-3010. PubMed ID: 27712973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
    Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA
    Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Role of Sphingolipids in Amphotericin B Drug Resistance.
    Madaan K; Bari VK
    Microb Drug Resist; 2023 Aug; 29(8):319-332. PubMed ID: 37327022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement effect of N-methyl-N″-dodecylguanidine on the vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans.
    Yutani M; Ogita A; Usuki Y; Fujita K; Tanaka T
    J Antibiot (Tokyo); 2011 Jul; 64(7):469-74. PubMed ID: 21522157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus.
    Makarasen A; Reukngam N; Khlaychan P; Chuysinuan P; Isobe M; Techasakul S
    J Mycol Med; 2018 Mar; 28(1):112-121. PubMed ID: 29276078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.